Birth Defects Research
AUTHOR GUIDELINES
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted via the journal’s ScholarOne site: https://mc.manuscriptcentral.com/bdr. For more details on how to use ScholarOne, visit www.wileyauthors.com/scholarone. Note, this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
The submission system will prompt the author to use an ORCiD ID (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at authorservices.wiley.com/statements/data-protection-policy.
For help with submissions, authors should contact the Editorial Office: bdr@wiley.com. When necessary, the Editorial Office staff may refer questions to the Editor-in-Chief.
2. AIMS AND SCOPE
Birth Defects Research is an official publication of the Society for Birth Defects Research and Prevention. Society members receive an electronic subscription to the journal as part of membership dues. Society members may pay an additional fee to receive the journal in printed form. For more information on becoming a member, visit the Society's website: www.birthdefectsresearch.org.
The journal Birth Defects Research publishes original research and reviews in areas related to the etiology of adverse developmental and reproductive outcome. In particular the journal is devoted to the publication of original scientific research that contributes to the understanding of the biology of embryonic development and the prenatal causative factors and mechanisms leading to adverse pregnancy outcomes, namely structural and functional birth defects, pregnancy loss, postnatal functional defects in the human population, and to the identification of prenatal factors and biological mechanisms that reduce these risks.
Adverse reproductive and developmental outcomes may have genetic, environmental, nutritional or epigenetic causes. Accordingly, Birth Defects Research takes an integrated, multidisciplinary approach in its organization and publication strategy. The journal Birth Defects Research contains separate sections for clinical and molecular teratology, developmental and reproductive toxicology, and reviews in developmental biology to acknowledge and accommodate the integrative nature of research in this field. Each section has a dedicated editor who is a leader in his/her field and who has full editorial authority in his/her area.
The journal Birth Defects Research publishes work in the following areas:
Environmental, genetic and epigenetic factors, and their interactions, causing birth defects demonstrated by clinical epidemiology
Cellular and molecular causative mechanisms of adverse developmental and reproductive outcomes in animal models
Novel insights from genomic, transcriptomic, proteomic and metabolomic approaches
Protective factors in humans and their mechanisms in animal models
Reproductive and developmental toxicity of drugs, chemicals and biotechnology-derived products in organismal, cellular and computational models:
endocrine-mediated reproductive and developmental toxicity;
protocols for evaluating developmental and reproductive toxicity, ranging from computational models to regulatory bioassays;
physiologically based pharmacokinetic (PBPK) mathematical modeling of pregnancy and delivery of agents to the developing organism;
approaches to risk assessment for developmental and reproductive toxicants;
toxicity related to direct exposure in juvenile animals
Topical, multi-disciplinary and state-of-the-art review articles that capture exciting advances in normal and abnormal developmental and reproductive biology
Birth Defects Research is published in twenty issues per year.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Online Submission:
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/bdr. Check for an existing account. If you are submitting for the first time, and you do not have an existing account, create a new account.
During the submission process, you will be asked to select the subject of your manuscript:
Clinical and Molecular Teratology
Developmental and Reproductive Toxicology
Embryo Today: Reviews (editor-invited submissions)*
*Please contact Michiko Watanabe (mxw13@case.edu) regarding invited papers on the subject of “Embryo Today: Reviews”.
Manuscript Types
Research Article (all subjects): Manuscripts in this category describe the results of original research conducted in the broad area of birth defects research. The manuscript should be presented in the format of Abstract, Introduction, Methods, Results, and Discussion. The abstract should be structured as follows: Background, Methods, Results, and Conclusions (250-word limit).
Review (all subjects): Review articles focus on topics of broad scientific interest to investigators in the area of birth defects research. Although such articles are usually solicited by the Editors, the journal will consider author-initiated proposals. Please contact the Editor if you wish to propose a Review Article.
Brief Report (Clinical and Molecular Teratology only): Narrower in scope than Research Articles, Brief Reports may present results of studies that involve small sample sizes, introduce new methodologies, report new developments, or describe preliminary results that are experimentally well documented. The Methods should be sufficiently detailed to permit replication of the work. Results and Discussion should be separate sections. Brief Reports should not exceed 2000 words of text, 2 tables or figures, and 25 references. The Abstract should follow the same form (structured) and word length (not >250 words) as required for Research Articles.
Case Report (Clinical and Molecular Teratology only): These articles may describe one or more cases of a unique or rare clinical syndrome. The Abstract for a Case Report should be structured as Background, Case(s), and Conclusions. The text should use the following format: Introduction, Case Report, and Discussion. The Discussion is expected to place the subject(s) of the Case Report in the context of the published literature on the same or related birth defect and to discuss the possible pathogenesis of the malformation.
Hypothesis (Clinical and Molecular Teratology only): These articles present new data that lead to a specific hypothesis warranting further research (see BDRA 67 (3):149-153,2003 and 67(6):403-408, 2003 for examples). The format of Hypothesis articles should follow those outlined for Research Articles.
Teratogen Update (Clinical and Molecular Teratology only): These articles review in detail the epidemiology, animal data, pharmacokinetics, toxicokinetics, or mechanism of action of a particular teratogenic agent or group of agents,e.g., anticonvulsants. These in-depth articles are usually solicited by the Editor, but the journal will consider proposals from potential authors.
Guidelines (Clinical and Molecular Teratology only): These articles set forth guidelines related to the understanding and prevention of birth defects (see BDRA 67 (3):193 -201,2003 for an example). Guidelines should be formatted with the same organization as Research Articles.
Workshop Summary (Clinical and Molecular Teratology only): Summaries of workshops with a focus on birth defect-related topics will be considered. Authors interested in submitting such a summary should contact the Editor. Workshop Summary should be formatted with the same organization as a Brief Report.
Correspondence (Clinical and Molecular Teratology only): Letters to the Editor must refer to an article that appeared within the previous 2 months. The text of the letter should be brief (not >500 words), and the letter may include 1 table or figure and 10 references. No new data may be presented. Letters to the Editor will be sent to the authors of the initial article for response. If accepted, both letters will be published in the same issue.
MGGM cover
NOTE: Birth Defects Research supports Molecular Genetics & Genomic Medicine (MGGM), a Wiley Open Access interdisciplinary journal that publishes quality research in human, medical and molecular genetics. With a broad scope and inclusive approach to publishing, MGGM provides a reputable outlet for rigorously peer-reviewed and well-conducted scientific research articles across its broad scope. For more information, visit the journal’s homepage.
MGGM is supported by this and numerous other journals published by Wiley; a complete list is available here. Authors of manuscripts deemed unsuitable for publication in Birth Defects Research may be offered the opportunity to redirect their manuscript to MGGM via the Wiley Manuscript Transfer Program. The transfer is automatic, saving the author valuable time. Moreover, any peer review evaluation previously conducted by Birth Defects Research travels with the transferred manuscript and may be used by the Editors of MGGM in their evaluation of the paper. By repurposing the reviews, the burden of peer review on the scientific community is decreased and authors receive a faster evaluation by MGGM. If accepted for publication in MGGM, a Wiley Open Access journal, authors receive a 20% discount on the associated Article Publication Charge (APC).
4. PREPARING THE SUBMISSION
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures.
1. Main Text File
The text file should be presented in the following order:
The title;
The full names of the authors (do not include academic degrees);
The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
Grant numbers (as applicable-to ensure proper identification of funders with publication requirements-see note under Author Licensing; below);
Abstract and keywords;
Main text;
Acknowledgments;
References;
Tables (each table complete with title and footnotes);
Figure legends;
Appendices (if relevant)
Figures and supplementary or supporting information should be supplied as separate files (see below under “Additional Files”). Figures must be clearly labeled.
Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Acknowledgements
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the Conflict of Interest section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Abstract
Please provide an abstract of 250 words containing the major keywords summarizing the article.
Keywords
Please provide three to five keywords.
Main Text
The journal uses US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.
References
The accuracy of references is the responsibility of the authors. Only published papers and those in press may be included in the reference list. Unpublished data and submitted manuscripts must be cited parenthetically within the text. Personal communications should also be cited within the text; permission in writing from the communicator is required.
References should be prepared according to the Publication Manual of the American Psychological Association (6th edition). The APA website includes a range of resources for authors learning to write in APA style, including an overview of the manual, free tutorials on APA Style basics, and an APA Style Blog. For more information about APA referencing style, please also refer to the APA FAQ.
EndNote users can download the style here.
According to APA style, in text citations should follow the author-date method whereby the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically by name at the end of the paper.
Authors should note that the APA referencing style requires that a Digital Object Identifier (DOI) be provided for all references where available. Also, for journal articles, issue numbers are not included unless each issue in the volume begins with page one.
Reference examples follow:
Journal article
Beers, S. R., & De Bellis, M. D. (2002). Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. The American Journal of Psychiatry, 159, 483–486. doi:10.1176/appi.ajp.159.3.483
Book
Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: Infancy through high school (2nd ed.). Austin, TX: Pro-ed.
Internet Document
Norton, R. (2006, November 4). How to train a cat to operate a light switch [Video file]. Retrieved from http://www.youtube.com/watch?v=Vja83KLQXZs
Footnotes
Footnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be kept to a minimum. Keep footnotes brief; they should contain only short comments tangential to the main argument of the paper and should not include references. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals.
Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P- values. Statistical measures such as SD or SEM should be identified in the headings.
Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Figures
Although authors are encouraged to send the highest quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post- acceptance figure requirements.
Figures submitted in color will be published in color free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.
Additional Files
Supporting Information
Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.
Click here for Wiley’s FAQs on Supporting Information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
General Style Points
The following points provide general advice on formatting and style.
Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
Numbers under 10 should be spelt out, except for: measurements with a unit (8 mmol/L); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
The word “data” is plural; therefore, text should follow accordingly (for example, “The data show…the data are … the data were…”).
Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
Wiley Author Resources
Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.
Editing, Translation, and Formatting Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Papers will only be sent to review if the Editors determine that the paper meets the appropriate quality and relevance requirements.
Except where otherwise stated, manuscripts are single-blind peer reviewed. Wiley's policy on the confidentiality of the review process is available here.
Data Sharing and Data Accessibility
Birth Defects Research recognizes the many benefits of archiving research data. We expect you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles (https://www.force11.org/group/fairgroup/fairprinciples). All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Authors will be required to confirm adherence to the policy. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data, then you must provide the appropriate data availability statement. This journal notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). Sample statements are available here from Wiley Author Services. When published, all statements will be placed in the heading of your article.
Data Citation
Please also cite the data you have shared, like you would cite other sources that your article refers to, in your references section. You should follow the format for your data citations laid out in the Joint Declaration of Data Citation Principles, https://www.force11.org/datacitationprinciples:
[dataset] Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)
Human Studies and Subjects
For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical PracticeUS Federal Policy for the Protection of Human Subjects;. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.
Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (an eye bar must not be used because of insufficient de- identification). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.
Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:
US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
European authors outside the UK should conform to Directive 2010/63/EU.
Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers are included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the Abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.
Research Reporting Guidelines
Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognized research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:
Randomiz ed trials: CONSORT
Observational studies: STROBE
Systematic reviews: PRISMA
Case reports: CARE
Qualit ative research: SRQR
Diagnost ic / prognostic studies: STARD
Quality improvement studies: SQUIRE
Animal pre-clinical studies: ARRIVE
Study protocols: SPIRIT
Clini cal practice guidelines: AGREE
We also encourage authors to refer to and follow guidelines from:
Future of Research Communications and e-Scholarship (FORCE11)
National Research Council's Institute for Laboratory Animal Research guidelines
The Gold Standard Publication Checklist from Hooijmans and colleagues
Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI) website
FAIRsharing website
Species Names
Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.
Genetic Nomenclature
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.
Human gene nomenclature should follow the standards of the HUGO Gene Nomenclature Committee (HGNC), see https://www.genenames.org/
Sequence Data
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:
DNA Data Bank of Japan (DDBJ): www.ddbj.nig.ac.jp
EMBL Nucleotide Archive: ebi.ac.uk/ena
GenBank: www.ncbi.nlm.nih.gov/genbank
Protein sequence data should be submitted to either of the following repositories.
Protein Information Resource (PIR): pir.georgetown.edu.
SWISS-PROT: expasy.ch/sprot/sprot- top
Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.
Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: www.crossref.org/services/funder-registry.
Authorship
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:
Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
Been involved in drafting the manuscript or revising it critically for important intellectual content;
Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.
Additional Authorship Options
Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’
Wiley's Author Name Change Policy
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.
Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
6. AUTHOR LICENSING
If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.
For authors signing the copyright transfer agreement
If the open access option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs.
For authors choosing open access
If the open access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License (CC-BY) OAA
Creative Commons Attribution Non-Commercial License (CC-BY-NC) OAA
Creative Commons Attribution Non-Commercial -NoDerivs License (CC-BY-NC-ND) OAA
General information regarding licensing and copyright is available on the Wiley Author Services and the Wiley Open Access websites.
Note to NIH, The Wellcome Trust and the Research Councils UK Grantees
Pursuant to NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. Please click here for further information. If you select the open access option and your research is funded by The Wellcome Trust or the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in compliance with The Wellcome Trust and Research Councils UK requirements.
Self-Archiving Definitions and Policies
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted Articles
All accepted manuscripts are subject to editing. Authors have final approval of changes prior to publication.
Proofs
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.
Publication Charges
Color figures. Figures submitted in color will be published in color free of charge.
8. POST PUBLICATION
Access and Sharing
When the article is published online:
The author receives an email alert (if requested).
The link to the published article can be shared through social media.
The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.
For additional important information on Wiley’s Article Sharing policy, click here.
Print copies of the article can now be ordered (instructions are sent at proofing stage or email chris.jones@sheridan.com.
Promoting the Article
To find out how to best promote an article, click here.
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Measuring the Impact of an Article
Wiley also helps our authors easure the impact of their research through specialist partnerships with Kudos ) and Altmetric .
9. EDITORIAL OFFICE CONTACT DETAILS
Editor-in-Chief:
Michel Vekemans, MD, PhD
Paris, France
Email : m_vekemans@yahoo.fr
Editorial Office: bdr@wiley.com
Journal Production
Alverne Ball: bdr2prod@wiley.com
Author Guidelines updated February 17, 2021
